COLUMBIA, Md., Sept. 9, 2015 /CNW/ -- Chesapeake IRB (www.chesapeakeirb.com), the industry's leading IRB in operational excellence and customer focus, recently completed its acquisition of Liberty IRB, Inc., a full-service institutional review board headquartered in Deland, Florida.
The Liberty acquisition broadens the organization's reach and adds additional review capacity according to Jeff Wendel, President of Chesapeake IRB.
"Adding Liberty IRB to the Chesapeake team of companies is another positive step in realizing our strategic growth plans," he said. "Liberty IRB shares Chesapeake's core values of commitment to human subject protection, quality customer service and regulatory compliance. Our combined organizations greatly enhance our capabilities to serve our clients."
This is the most recent of several acquisitions that Chesapeake IRB has completed since 2013.
Liberty IRB and Chesapeake IRB, are providers of federally mandated institutional review board ("IRB") services to pharmaceutical, biotech and medical device companies, universities, academic medical centers, hospital systems, governmental entities and others required to use IRB services to assure the protection of rights and the welfare of human subjects participating in research.
For additional information regarding Chesapeake IRB please contact:
Ruth Boulter, Vice President, Business Development, 410-884-2900, email@example.com
SOURCE Chesapeake IRB